Foresite Capital Management II’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-146,800
| Closed | -$2.77M | – | 7 |
|
|
2019
Q3 | $2.77M | Sell |
146,800
-1,439,420
| -91% | -$27.2M | 0.59% | 7 |
|
|
2019
Q2 | $18.7M | Hold |
1,586,220
| – | – | 10.5% | 5 |
|
|
2019
Q1 | $21.7M | Hold |
1,586,220
| – | – | 9.78% | 4 |
|
|
2018
Q4 | $16.3M | Hold |
1,586,220
| – | – | 8.62% | 3 |
|
|
2018
Q3 | $26.4M | Sell |
1,586,220
-100,000
| -6% | -$1.67M | 9.77% | 3 |
|
|
2018
Q2 | $26.6M | Hold |
1,686,220
| – | – | 9.39% | 3 |
|
|
2018
Q1 | $21.4M | Buy |
1,686,220
+642,388
| +62% | +$8.16M | 7.12% | 5 |
|
|
2017
Q4 | $12M | Hold |
1,043,832
| – | – | 4.18% | 5 |
|
|
2017
Q3 | $12.8M | Hold |
1,043,832
| – | – | 5.18% | 4 |
|
|
2017
Q2 | $12M | Buy |
1,043,832
+87,791
| +9% | +$1.01M | 5.48% | 4 |
|
|
2017
Q1 | $19.9M | Sell |
956,041
-39,355
| -4% | -$819K | 8.53% | 4 |
|
|
2016
Q4 | $20.7M | Buy |
995,396
+192,672
| +24% | +$4.01M | 10.39% | 3 |
|
|
2016
Q3 | $26.3M | Buy |
802,724
+201,795
| +34% | +$6.61M | 12.56% | 3 |
|
|
2016
Q2 | $15M | Buy |
600,929
+70,513
| +13% | +$1.76M | 10.26% | 4 |
|
|
2016
Q1 | $13M | Buy |
530,416
+110,419
| +26% | +$2.7M | 6.36% | 7 |
|
|
2015
Q4 | $13.9M | Buy |
419,997
+75,227
| +22% | +$2.48M | 4.65% | 8 |
|
|
2015
Q3 | $11.3M | Hold |
344,770
| – | – | 3.43% | 9 |
|
|
2015
Q2 | $18.3M | Buy |
344,770
+187,639
| +119% | +$9.94M | 6.41% | 7 |
|
|
2015
Q1 | $4.54M | Sell |
157,131
-87,869
| -36% | -$2.54M | 2.69% | 12 |
|
|
2014
Q4 | $7.13M | Buy |
+245,000
| New | +$7.13M | 4.88% | 5 |
|